Physician profile
Kristy M Panichelli
NPI 1578693552
$2,349.50
in general payments reported to CMS, 2019-2025
13 companies · $749 in 2025
The $749 reported for 2025 was more than what 83% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $322 · 2023: $545 · 2024: $733 · 2025: $749.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,027.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,027.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $500.15 | 2022-2025 | Jardiance |
| Abbott Laboratories | $469.05 | 2022-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit, Jot Dx |
| Medtronic, INC. | $252.30 | 2022-2024 | Closurefast, Cobalt Dr Mri Surescan, Micra |
| Amgen INC. | $221.94 | 2024-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $184.34 | 2023-2025 | Eliquis |
| Impulse Dynamics (USA) INC. | $179.87 | 2023 | Optimizer |
| Merck Sharp & Dohme LLC | $125.00 | 2023 | Verquvo |
| Janssen Pharmaceuticals, INC | $121.97 | 2022 | |
| Scpharmaceuticals INC. | $101.74 | 2023-2025 | |
| Bridgebio Pharma, INC. | $93.67 | 2025 | Attruby |
| Pfizer INC. | $59.44 | 2024-2025 | |
| Esperion Therapeutics, INC. | $21.14 | 2024 | Nexletol |
| Astrazeneca Pharmaceuticals LP | $18.89 | 2025 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristy Panichelli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.